Abstract

At present, industries within the health and life science sector are moving towards one another resulting in new industries such as the medical nutrition industry. Medical nutrition products are specific nutritional compositions for intervention in disease progression and symptom alleviation. Industry convergence, described as the blurring of boundaries between industries, plays a crucial role in the shaping of new markets and industries. Assuming that the medical nutrition industry has emerged from the convergence between the food and pharma industries, it is crucial to research how and which distinct industry domains have contributed to establish this relatively new industry. The first two stages of industry convergence (knowledge diffusion and consolidation) are measured by means of patent analysis. First, the extent of knowledge diffusion within the medical nutrition industry is graphed in a patent citation interrelations network. Subsequently the consolidation based on technological convergence is determined by means of patent co-classification. Furthermore, the medical nutrition core domain and technology interrelations are measured by means of a cross impact analysis. This study proves that the medical nutrition industry is a result of food and pharma convergence. It is therefore crucial for medical nutrition companies to effectively monitor technological developments within as well as across industry boundaries. This study further reveals that although the medical nutrition industry’s core technology domain is food, technological development is mainly driven by pharmaceutical/pharmacological technologies Additionally, the results indicate that the industry has surpassed the knowledge diffusion stage of convergence, and is currently in the consolidation phase of industry convergence. Nevertheless, while the medical nutrition can be classified as an industry in an advanced phase of convergence, one cannot predict that the pharma and food industry segments will completely converge or whether the medical industry will become an individual successful industry.

Highlights

  • The Health & Life Sciences sector is currently undergoing significant change across all its industries

  • First we determine the extent of knowledge diffusion within the Medical Nutrition (MN) industry, subsequently we define the consolidation into the MN industry on the basis of technological convergence (Fig. 2), and eventually we identify the MN core domains and chart the technology interrelation and its influence on the MN industry development

  • This study proves that the MN industry is a result of a bona fide food-pharma convergence

Read more

Summary

Introduction

The Health & Life Sciences sector is currently undergoing significant change across all its industries. Boundary-crossing developments are occurring, especially between the food and pharmaceutical industries. Food-pharma products resulting from this convergence are known as Nutritional Supplements (NS), Functional Foods (FF), and Medical Nutrition (MN). FF are conventional foods with added nutrients that claim to improve health beyond the basic nutritional functions [3,4,5,6,7,8]. The individual pharmaceutical and food companies recognize the risks in developing food-pharma inventions[10,12]. They fear that the commercialization of boundary-spanning products [7] could result in a lower customer acceptance due to the ambiguous identity of the product [7]

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call